iifl-logo

Fortis Healthcare Ltd Profit & Loss Statement

670.6
(2.44%)
Apr 28, 2025|11:24:57 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

862.61

632.87

701.84

659.48

yoy growth (%)

36.3

-9.82

6.42

2.22

Raw materials

-204.28

-150.57

-147.47

-135.56

As % of sales

23.68

23.79

21.01

20.55

Employee costs

-154.23

-147.65

-155.44

-161.34

As % of sales

17.87

23.33

22.14

24.46

Other costs

-388.68

-306.73

-330.99

-400.19

As % of sales (Other Cost)

45.05

48.46

47.15

60.68

Operating profit

115.4

27.9

67.93

-37.62

OPM

13.37

4.4

9.68

-5.7

Depreciation

-112.62

-110.77

-96.81

-28.87

Interest expense

-129.57

-141.44

-160.16

-63.73

Other income

134.09

191.98

938.34

137.89

Profit before tax

7.29

-32.32

749.3

7.65

Taxes

-4.26

-19.93

-107.34

-3.42

Tax rate

-58.45

61.66

-14.32

-44.77

Minorities and other

0

0

0

0

Adj. profit

3.02

-52.26

641.95

4.22

Exceptional items

-16.28

56.45

-128.62

-67.94

Net profit

-13.25

4.19

513.32

-63.71

yoy growth (%)

-415.67

-99.18

-905.62

-14.69

NPM

-1.53

0.66

73.13

-9.66

Fortis Health. : related Articles

Fortis Healthcare’s Subsidiary IHL Faces ₹76.19 Crore Tax Demand
4 Apr 2025|12:05 PM

The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.

Read More
Top Stocks for Today - 4th April 2025
4 Apr 2025|07:43 AM

Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.

Read More
Fortis Healthcare Q3 Profit Soars 89.5% YoY, Revenue Up 14.8%
9 Feb 2025|10:53 PM

EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.

Read More
Fortis Healthcare Boosts Stake in Agilus Diagnostics with ₹429 Crore IFC Deal
23 Dec 2024|11:59 AM

The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.

Read More
Fortis Healthcare Reports 1.6% Profit Growth, 12.3% Revenue Increase in Q2
12 Nov 2024|12:03 PM

Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.

Read More
Fortis Buys Out PE Investors in Diagnostics Arm
9 Aug 2024|08:32 AM

Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.